Menu
Not yet recruiting NCT07596537

The Effect of Detrusor Underactivity in Determining Outcomes After Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia

No phase Interventional Detrusor Underactivity Transurethral Resection of the Prostate (TURP)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: transurethral resection of Prostate.
Who it may be relevant to
Registry conditions: Detrusor Underactivity, Transurethral Resection of the Prostate (TURP). Basic parameters: from 50 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this clinical trial is to evaluate the effect of detrusor underactivity on the functional and symptomatic outcomes following transurethral resection of the prostate (TURP) in benign prostatic hyperplasia patients presenting with chronic urinary retention. The main questions it aims to answer are: Will they restore spontaneous voiding? They will be divided into 2 comparative groups (each group 45 patients) based on detrusor contractility. * Group (A) consists of patients with normal detrusor (bladder contractility index more than 100). * Group (B) consists of patients with underactive detrusor (bladder contractility index less than 100).

Interventions

  • Procedure transurethral resection of Prostate
    Standard TURP

Primary outcome measures

  • Restore spontaneous voiding [Time frame: 3 months]
Secondary outcome measures (2)
  • Flow rate improvement [Time frame: 3 months]
  • Post voiding residual urine volume decrease [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • Age: more than 50-year-old
  • Chronic urinary retention secondary to BPH
  • Prostate size Above 30 and less than 100gm

Exclusion criteria

  • Prostate size over 100 gm and less than 30 gm
  • Prostatic carcinoma
  • Urinary bladder carcinoma
  • Acute urinary retention
  • Urethral stricture.
  • Previous bladder, urethral or prostate surgery.
  • Acute urinary tract infection.
  • Neurogenic bladder

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07596537 · Detrusor Underactivity & TURP

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗